Arcutis Biotherapeutics director Howard G. Welgus disposes of 4,731 common shares for $115,957.48

Arcutis Biotherapeutics

Arcutis Biotherapeutics

ARQT

0.00
  • Arcutis Biotherapeutics director Howard G. Welgus cut his direct stake to 37,743 shares following option exercises and stock sales.
  • Welgus exercised options for 4,096 shares at prices ranging from $6.52 to $8.63 on June 15.
  • He sold 4,096 shares on June 15 at a weighted average price of $24.41, then sold 635 shares on June 17 at $25.67.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-044079), on June 17, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.